DelistingJun 12, 2026, 05:21 PM
Celularity Receives Nasdaq Delisting Notice for Low Market Value
AI Summary
Celularity Inc. received a notice from Nasdaq on June 9, 2026, indicating non-compliance with the minimum Market Value of Listed Securities (MVLS) requirement of $35 million. The company has been granted 180 calendar days, until December 7, 2026, to regain compliance. To do so, its market value must meet or exceed $35.0 million for a minimum of 10 consecutive business days. Celularity is evaluating options to address the deficiency, including potentially increasing its stockholders' equity.
Key Highlights
- Celularity Inc. received a Nasdaq notice on June 9, 2026, for failing to meet the $35 million minimum Market Value of Listed Securities (MVLS) requirement.
- The company has 180 calendar days, until December 7, 2026, to regain compliance with Nasdaq Listing Rule 5550(b)(2).
- To regain compliance, Celularity's market value must exceed $35.0 million for at least 10 consecutive business days.
- The notice does not immediately result in delisting of the company's common stock from the Nasdaq Capital Market.
- Celularity is evaluating potential actions to regain compliance, including monitoring market value or increasing stockholders' equity to $2.5 million.
- Failure to comply by December 7, 2026, could lead to a delisting notification, which the company may appeal.
Price Impact
More from CELU